| Name | CL2A |
|---|
| Description | CL2A is a complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker[1]. |
|---|---|
| Related Catalog | |
| Target |
Alkyl/ether |
| References |
[1]. Samantha Congreve, et al. Antibody drug conjugates (ADC). Teknisk- naturvetenskaplig fakultet |
| Molecular Formula | C51H79N9O18 |
|---|---|
| Molecular Weight | 1106.22 |